4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-061537
EVP, CBO, GC & Secretary sold 137,061 shares at an average $17.53 ($2,402,227)
- EVP, CBO, GC & Secretary acquired 137,061 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Primiano Christopher Brett · EVP, CBO, GC & Secretary
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 1 in the form | +78,124 | $10.45 | $816,396 | 82,647 | D |
| 2020-12-01 | Sale : show line 2 in the form | −78,124 | $17.66 | $1,379,670 | 4,523 | D |
| 2020-12-01 | Exercise or conversion : show line 3 in the form | +58,937 | $10.39 | $612,355 | 63,460 | D |
| 2020-12-01 | Sale : show line 4 in the form | −58,937 | $17.35 | $1,022,557 | 4,523 | D |
| Open-market sales · 137,061 sh · avg $17.53 · $2,402,227 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-12-01 | Exercise or conversion : show line 5 in the form Stock Option (right to buy) | −78,124 | $10.45 | 2028-01-23 | 78,124 | 46,876 | D |
| 2020-12-01 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −58,937 | $10.39 | 2027-01-19 | 58,937 | 16,842 | D |
Loading xslF345X03/doc4.xml…